# Kutaja (Holarrhena antidysenterica)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/kutaja
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-30
**Evidence Score:** 2 / 10
**Category:** Ayurveda
**Also Known As:** Holarrhena antidysenterica, Kurchi, Conessi bark, Tellicherry bark, Indrajau, Kuda, Korchi, Indian blackboard tree, Easter tree, Bitter oleander, Connessi seeds

## Overview

Kutaja (Holarrhena antidysenterica) is an Ayurvedic herb whose seeds and bark contain steroidal alkaloids, most notably conessine, which inhibits [acetylcholine](/ingredients/condition/cognitive)sterase and exhibits broad-spectrum [antimicrobial](/ingredients/condition/immune-support) activity. Its primary traditional application is in treating diarrhea, dysentery, and digestive disorders, with modern interest driven by conessine's measurable enzyme-inhibitory activity in laboratory models.

## Health Benefits

• Traditional anti-diarrheal and anti-dysentery effects (traditional use only, no clinical trials found in research)
• Potential [acetylcholine](/ingredients/condition/cognitive)sterase inhibition from seed alkaloids like conessine (IC50 4-20 μg/ml, in vitro evidence only)
• Traditional use for digestive disorders including dyspepsia, colic, and flatulence (historical use, no clinical evidence)
• [Antimicrobial](/ingredients/condition/immune-support) properties attributed to steroidal alkaloids (traditional claim, no clinical studies cited)
• Traditional wound healing when bark decoction applied topically (historical use only)

## Mechanism of Action

Conessine, a steroidal alkaloid isolated from Holarrhena antidysenterica seeds, inhibits [acetylcholine](/ingredients/condition/cognitive)sterase with an IC50 of approximately 4–20 μg/ml in vitro, potentially modulating cholinergic neurotransmission. The bark's tannins and alkaloids may reduce intestinal motility and fluid secretion by interacting with opioid-like pathways and inhibiting pro-inflammatory mediators such as [prostaglandin](/ingredients/condition/inflammation)s, contributing to its anti-diarrheal effect. Additionally, conessine has demonstrated in vitro [antimicrobial](/ingredients/condition/immune-support) activity against Entamoeba histolytica and certain bacterial pathogens, suggesting a direct anti-infective component to its digestive benefits.

## Clinical Summary

No randomized controlled clinical trials on Kutaja or isolated conessine in human subjects were identified in the peer-reviewed literature as of the current research review. Evidence supporting anti-diarrheal and anti-dysenteric effects derives predominantly from traditional Ayurvedic use documented over centuries, supported by in vitro [antimicrobial](/ingredients/condition/immune-support) and enzyme-inhibition assays. Animal model studies have shown reductions in castor oil-induced diarrhea and intestinal transit time with bark extracts, but sample sizes and methodological rigor limit generalizability. Overall, the evidence base is preclinical and traditional; human efficacy and optimal dosing remain unestablished.

## Nutritional Profile

Kutaja (Holarrhena antidysenterica) is a medicinal plant used primarily for its bioactive phytochemical content rather than macronutrient value. It is not consumed as a food, so conventional nutritional profiling (calories, protein, fat, carbohydrates, fiber) is not applicable in dietary terms. The pharmacological value resides in its rich alkaloid and phytochemical composition:

**Primary Bioactive Alkaloids (primarily in stem bark and seeds):**
• Conessine — the principal steroidal alkaloid, reported at approximately 0.5–2.5% w/w of dried bark; concentration in seeds may reach 2–4% w/w. Responsible for much of the anti-amoebic and anti-diarrheal activity.
• Conessimine — structurally related to conessine, present at approximately 0.1–0.5% w/w of dried bark.
• Kurchine (Holarrhimine) — approximately 0.05–0.3% w/w in bark.
• Isoconessimine — trace to minor concentrations (~0.05–0.2% w/w).
• Holarrhenine, Holarrhine, Kurchicine, Kurcholessine — present in trace to minor quantities collectively contributing to a total alkaloid content of approximately 2–5% in dried bark.
• Total steroidal alkaloid count: over 40 identified alkaloids across plant parts.

**Other Bioactive Compounds:**
• Flavonoids — including quercetin and kaempferol glycosides, present in leaves (estimated total flavonoid content ~1.5–3.5 mg quercetin equivalents/g dry weight of leaf extract).
• Phenolic acids — gallic acid, caffeic acid, and ellagic acid derivatives; total phenolic content in bark extracts approximately 25–60 mg gallic acid equivalents (GAE)/g dry extract depending on solvent system.
• Tannins — moderate concentration in bark (~3–8% w/w), contributing to astringent and anti-diarrheal properties.
• Saponins — present in bark and seeds in minor quantities.
• Triterpenoids — including lupeol and related compounds in bark and leaves.
• Resinous substances — approximately 2–5% in bark.

**Mineral Content (bark, approximate from limited analyses):**
• Calcium: ~1,200–1,800 mg/100g dry bark
• Potassium: ~800–1,500 mg/100g dry bark
• Iron: ~15–40 mg/100g dry bark
• Magnesium: ~200–500 mg/100g dry bark
• Zinc, Manganese, Copper: present in trace quantities
(Note: These values are from elemental analyses of dried bark and are not bioavailable in the same manner as dietary minerals, since Kutaja is taken as a decoction or extract, not as a whole food.)

**Bioavailability Notes:**
• Conessine is lipophilic and shows reasonable oral absorption in animal models, crossing the blood-brain barrier (relevant to its [acetylcholine](/ingredients/condition/cognitive)sterase inhibitory activity). Human pharmacokinetic data are extremely limited.
• Tannins in bark may reduce the bioavailability of co-administered nutrients and minerals through chelation.
• Traditional Ayurvedic preparation as kashaya (decoction) or churna (powder) with buttermilk or honey is considered to enhance extraction and absorption of alkaloids.
• Alkaloid extraction efficiency is significantly influenced by preparation method: aqueous decoctions may extract 30–60% of total alkaloids, whereas hydroalcoholic extracts may recover 60–85%.
• Polyphenols and flavonoids have generally low oral bioavailability (typically <10% without formulation enhancement), though traditional co-administration with piperine-containing adjuvants (e.g., Trikatu) may improve uptake.

**Summary:** Kutaja's therapeutic relevance is driven by its steroidal alkaloid profile (especially conessine at 0.5–4% depending on plant part) and supporting phenolic/tannin content, rather than by conventional nutritional value. All concentration values are approximate and vary significantly by geographic origin, harvest season, plant part, and extraction methodology.

## Dosage & Preparation

No clinically studied dosage ranges are available in the research for any form of Kutaja. Traditional preparations include powder and decoctions from bark containing 1.5-4.2% steroidal alkaloids, but therapeutic doses have not been established through clinical research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Kutaja has a long history of traditional use in Ayurvedic practice, but formal human safety data are lacking, and high doses of conessine have demonstrated neurotoxic potential in animal studies, including convulsions at supra-therapeutic concentrations. The herb may theoretically potentiate anticholinesterase medications (e.g., donepezil, rivastigmine) due to additive cholinergic activity, and co-administration should be avoided without medical supervision. Conessine's structural similarity to steroid hormones raises theoretical concerns about hormonal interactions, though this has not been clinically documented. Kutaja is not recommended during pregnancy or lactation due to the absence of safety data and the known bioactivity of its alkaloids.

## Scientific Research

The research dossier reveals no human clinical trials, RCTs, or meta-analyses for Kutaja. Available evidence consists primarily of in vitro data, such as [acetylcholine](/ingredients/condition/cognitive)sterase inhibition by seed alkaloids, and traditional use documentation without modern clinical validation.

## Historical & Cultural Context

In Ayurveda, Kutaja has been used for centuries to treat diarrhea, dysentery, digestive disorders, skin diseases, and wounds. It is traditionally considered to balance Kapha and Pitta doshas, with bitter and astringent tastes (Tikta, Kashaya) and cold potency (Sheeta).

## Synergistic Combinations

Other Ayurvedic digestive herbs, Probiotics, [Digestive enzyme](/ingredients/condition/gut-health)s, Ginger, Triphala

## Frequently Asked Questions

### What is conessine and why is it important in kutaja?

Conessine is a steroidal alkaloid found in the seeds and bark of Holarrhena antidysenterica and is considered the primary bioactive compound of kutaja. It exhibits acetylcholinesterase inhibition (IC50 4–20 μg/ml in vitro) and antimicrobial activity against Entamoeba histolytica, making it the focus of pharmacological research into kutaja's traditional digestive and anti-dysenteric effects.

### Is kutaja effective for diarrhea and dysentery?

Kutaja has been used in Ayurvedic medicine for centuries specifically to treat diarrhea, dysentery, and amoebic infections, and animal studies have confirmed reductions in intestinal motility and fluid secretion with bark extracts. However, no human clinical trials have been conducted, so its effectiveness in humans cannot be confirmed by modern evidence standards, and it should not replace medically evaluated treatments for acute dysentery.

### What is the traditional Ayurvedic dosage of kutaja bark?

Traditional Ayurvedic texts typically recommend kutaja bark powder (churna) in doses of 3–6 grams per day, often combined with buttermilk or warm water for digestive complaints. Standardized extract doses vary by manufacturer and no clinically validated dosing protocol exists, so consultation with a qualified Ayurvedic practitioner or physician is advised before supplementation.

### Can kutaja interact with prescription medications?

Kutaja's conessine content may produce additive effects when combined with acetylcholinesterase inhibitors used for Alzheimer's disease (e.g., donepezil, galantamine), potentially increasing the risk of cholinergic side effects such as nausea, bradycardia, and excessive secretions. Due to conessine's steroidal alkaloid structure, theoretical interactions with hormonal therapies or CYP450-metabolized drugs are also plausible, though direct pharmacokinetic interaction studies in humans have not been published.

### Is kutaja safe during pregnancy?

Kutaja is not considered safe during pregnancy due to the complete absence of human safety data and the known pharmacological potency of its alkaloids, including conessine, which has demonstrated toxicity at elevated doses in animal models. Traditional Ayurvedic contraindications also caution against its use in pregnant and lactating women, and avoidance during these periods is the prudent recommendation until rigorous safety studies are available.

### What is the difference between kutaja bark and kutaja seeds, and which form is more commonly used?

Kutaja bark has been the primary form used in traditional Ayurvedic medicine for anti-diarrheal purposes, while the seeds contain higher concentrations of alkaloids like conessine with potential acetylcholinesterase-inhibiting properties. Bark preparations are more widely available and traditionally recommended, though seed extracts have been studied for their biochemical potential in laboratory settings. The choice between forms depends on traditional preparation methods and the specific health concern being addressed.

### How does kutaja work as an antimicrobial agent, and what microorganisms does it target?

Kutaja has been attributed with antimicrobial properties in traditional use, though specific mechanisms and targeted pathogens require further clinical investigation beyond historical records. Traditional practitioners have used it for conditions suspected to involve microbial involvement, such as dysentery and diarrheal infections. Modern research has not yet definitively established which bacterial or parasitic species are most susceptible to kutaja extracts in human applications.

### Who should consider kutaja supplementation, and for which digestive conditions is it traditionally recommended?

Kutaja has traditionally been recommended for individuals experiencing diarrhea, dysentery, dyspepsia, colic, and flatulence, particularly those seeking plant-based digestive support within Ayurvedic frameworks. It is most commonly considered for acute digestive disturbances rather than chronic gastrointestinal conditions, based on its historical use patterns. However, anyone considering kutaja should consult a healthcare provider, as clinical evidence for efficacy in humans remains limited.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*